Influence of kaolin--pectin suspension on digoxin bioavailability. 1978

K S Albert, and J W Ayres, and A R DiSanto, and D J Weidler, and E Sakmar, and M R Hallmark, and R G Stoll, and K A DeSante, and J G Wagner

The effect of a kaolin--pectin suspension on the bioavailability of orally administered digoxin was evaluated when both drugs were given concomitantly and when their time of administration was separated by 2 hr. Coadministration of the antidiarrheal with the cardiac glycoside delayed absorption of the latter and, at the same time, decreased by 62% the amount of drug absorbed. Intersubject variation in digoxin bioavailability also was increased more than twofold. When the kaolin--pectin suspension was given 2 hr before the cardiac glycoside, the digoxin absorption rate was not affected, although its relative extent of absorption was reduced by about 20%. In contrast, when the antidiarrheal was given 2 hr after digoxin, neither the rate nor the extent of absorption of the cardiac glycoside was perturbed. No change in the intersubject variability in digoxin bioavailability was noted whether the antidiarrheal was given 2 hr before or 2 hr after the cardiac glycoside.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007616 Kaolin The most common mineral of a group of hydrated aluminum silicates, approximately H2Al2Si2O8-H2O. It is prepared for pharmaceutical and medicinal purposes by levigating with water to remove sand, etc. (From Merck Index, 11th ed) The name is derived from Kao-ling (Chinese: "high ridge"), the original site. (From Grant & Hackh's Chemical Dictionary, 5th ed) Kaolinite
D010368 Pectins High molecular weight polysaccharides present in the cell walls of all plants. Pectins cement cell walls together. They are used as emulsifiers and stabilizers in the food industry. They have been tried for a variety of therapeutic uses including as antidiarrheals, where they are now generally considered ineffective, and in the treatment of hypercholesterolemia. Calcium Pectinate,Methoxy Pectin,Methoxylpectin,Methoxypectin,Pectin,Pectinic Acid,Zinc Pectinate,Pectin, Methoxy,Pectinate, Calcium,Pectinate, Zinc
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013535 Suspensions Colloids with liquid continuous phase and solid dispersed phase; the term is used loosely also for solid-in-gas (AEROSOLS) and other colloidal systems; water-insoluble drugs may be given as suspensions. Suspension

Related Publications

K S Albert, and J W Ayres, and A R DiSanto, and D J Weidler, and E Sakmar, and M R Hallmark, and R G Stoll, and K A DeSante, and J G Wagner
October 1981, Journal of clinical pharmacology,
K S Albert, and J W Ayres, and A R DiSanto, and D J Weidler, and E Sakmar, and M R Hallmark, and R G Stoll, and K A DeSante, and J G Wagner
June 1987, International journal of clinical pharmacology, therapy, and toxicology,
K S Albert, and J W Ayres, and A R DiSanto, and D J Weidler, and E Sakmar, and M R Hallmark, and R G Stoll, and K A DeSante, and J G Wagner
November 1976, The New England journal of medicine,
K S Albert, and J W Ayres, and A R DiSanto, and D J Weidler, and E Sakmar, and M R Hallmark, and R G Stoll, and K A DeSante, and J G Wagner
April 1983, Research communications in chemical pathology and pharmacology,
K S Albert, and J W Ayres, and A R DiSanto, and D J Weidler, and E Sakmar, and M R Hallmark, and R G Stoll, and K A DeSante, and J G Wagner
March 1968, Journal of pharmaceutical sciences,
K S Albert, and J W Ayres, and A R DiSanto, and D J Weidler, and E Sakmar, and M R Hallmark, and R G Stoll, and K A DeSante, and J G Wagner
January 1981, Journal of clinical pharmacology,
K S Albert, and J W Ayres, and A R DiSanto, and D J Weidler, and E Sakmar, and M R Hallmark, and R G Stoll, and K A DeSante, and J G Wagner
March 1991, Oral surgery, oral medicine, and oral pathology,
K S Albert, and J W Ayres, and A R DiSanto, and D J Weidler, and E Sakmar, and M R Hallmark, and R G Stoll, and K A DeSante, and J G Wagner
October 1991, Annals of internal medicine,
K S Albert, and J W Ayres, and A R DiSanto, and D J Weidler, and E Sakmar, and M R Hallmark, and R G Stoll, and K A DeSante, and J G Wagner
January 1984, International journal of clinical pharmacology research,
K S Albert, and J W Ayres, and A R DiSanto, and D J Weidler, and E Sakmar, and M R Hallmark, and R G Stoll, and K A DeSante, and J G Wagner
November 1978, Lancet (London, England),
Copied contents to your clipboard!